Tabitha G. Moe, M.D. FACC, M.D., FACC

Tabitha G. Moe, M.D. FACC

Biography

Dr. Tabitha Moe is a graduate of William Jennings Bryan College in Dayton, Tenn. She finished her undergraduate degree, graduating magna cum laude in only two and a half years with a major in Biology, double minors in Spanish and Bible. She then went on the attend medical school and Internal Medicine Residency at the University of Missouri-Kansas City. She attended Cardiovascular Disease Fellowship at the University of Arizona College of Medicine-Phoenix program at Banner University, and then completed additional training in congenital heart disease at Phoenix Children’s Hospital. She is board certified in Internal Medicine, Cardiovascular Diseases, and Adult Congenital Heart Disease.

She has become involved in the Adult Congenital Heart Association, serving on the Medical Advisory Board for the past 9 years and volunteering for the Walk for One in One Hundred as their annual fundraiser. She is active in the American College of Cardiology at the local and national levels, serving in the Adult Congenital and Pediatric Cardiology Advocacy Committee. She has also dedicated her time to serve as an Associate Editor for the Journal of the American College of Cardiology – Case Reports since that journal’s inception in 2018.

She has mentored Fellows in all of the Cardiovascular Fellowships in the Phoenix metro area over the past 10 years, including Mayo, Creighton, and U of A, as well as HonorHealth. She serves as the Associate Program Director of the HonorHealth Cardiovascular Diseases Fellowship.

She is an avid exerciser and traveler. She is married and she and her husband reside in Phoenix with their four children.

Research Interests & Focus

As one of only five board-certified Adult Congenital Cardiologists in Arizona, Tabitha’s primary work focuses on long-term outcomes of patients with complex congenital heart disease, including pregnancy in single ventricle disease, pulmonary hypertension in single ventricle physiology, and menopause in complex congenital heart disease.
She also is passionate about not adding insult to injury in this same population. As a result, a focus on cardiovascular outcomes research – including hypertension, lipids, and cardio-renal-metabolic diseases and the ways in which these same syndromes overlap with our ACHD patients – are a collateral focus.